Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2002
11/06/2002EP1254222A1 Human gaba receptor proteins and polynucleotides encoding the same
11/06/2002EP1254221A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
11/06/2002EP1254220A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
11/06/2002EP1254219A2 Nucleic acids, proteins, and antibodies
11/06/2002EP1254218A2 Nucleic acids, proteins, and antibodies
11/06/2002EP1254214A2 Human protein kinases and protein kinase-like enzymes
11/06/2002EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002EP1254176A2 Trade molecules and uses related thereto
11/06/2002EP1254175A1 Human cystine knot polypeptide
11/06/2002EP1254174A2 Human cyr61
11/06/2002EP1254173A1 Nucleic acids, proteins, and antibodies
11/06/2002EP1254172A1 Nucleic acids, proteins, and antibodies
11/06/2002EP1254168A2 Cytokine inhibittory molecules from tick salivary glands
11/06/2002EP1254166A2 Recombinant production of human histone-1 subtypes and use thereof for therapeutic purposes
11/06/2002EP1254164A2 Selective n-acylation of a82846 glycopeptide analogs
11/06/2002EP1254162A2 Kahalalide f and related compounds
11/06/2002EP1254161A2 Aerothricin analogs, their preparation and use
11/06/2002EP1254159A2 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/06/2002EP1254153A2 Nucleic acids, proteins, and antibodies
11/06/2002EP1254152A2 Nucleic acids, proteins, and antibodies
11/06/2002EP1254151A1 Nucleic acids, proteins, and antibodies
11/06/2002EP1254147A2 Nucleic acids, proteins, and antibodies
11/06/2002EP1254141A1 Camptothecin -beta-alanine esters with topoisomerase i inibhition
11/06/2002EP1254113A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
11/06/2002EP1254108A1 Gamma-secretase inhibitors
11/06/2002EP1254106A1 Calcilytic compounds
11/06/2002EP1253946A2 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
11/06/2002EP1253943A2 Photodynamic therapy for treating conditions of the eye
11/06/2002EP1253942A1 Cd40-binding apc-activating molecules
11/06/2002EP1253941A1 Pre-transplant accommodated organs resistant to anti-donor immunity
11/06/2002EP1253939A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
11/06/2002EP1253937A2 Methods of therapy with thrombin derived peptides
11/06/2002EP1253936A2 Microencapsulation and sustained release of biologically active agent
11/06/2002EP1253935A2 Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
11/06/2002EP1253933A2 Method for treating thyroid disorders
11/06/2002EP1253932A2 Botulinum toxin pharmaceutical compositions
11/06/2002EP1253931A2 Utilization of protein kinase inhibitor alpha
11/06/2002EP1253930A2 Method and compositions for treating hepatocellular cancer
11/06/2002EP1253929A1 Use of relaxin to treat diseases related to vasoconstriction
11/06/2002EP1253928A2 Novel haptotactic peptides
11/06/2002EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002EP1253923A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
11/06/2002EP1253915A1 Method for treating stress with a precursor of serotonin
11/06/2002EP1109818B1 Phosphoepoxides, method for making same and uses
11/06/2002EP1091966B1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace)
11/06/2002EP1007065A4 Preparation of collagen
11/06/2002EP0909277A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
11/06/2002EP0906338B1 Glucagon-like peptide-2 analogs
11/06/2002EP0888386B1 Stable factor viii/ von willebrand factor complex
11/06/2002EP0800528B1 Peptide and peptide analog protease inhibitors
11/06/2002EP0773959B1 Adrenergic receptor
11/06/2002EP0741577B1 The use of interferon subtype alpha 8 in the preparation of medicaments to treat viral infections of the liver
11/06/2002EP0726758B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
11/06/2002EP0689550B1 Antimicrobial peptides from bovine neutrophils
11/06/2002CN1378595A Human cytokine as ligand of zalpha receptor and use thereof
11/06/2002CN1378594A T-cell receptor gamma alternate reading frame protein (TARP) and uses thereof
11/06/2002CN1378552A Novel transcription factor BP1
11/06/2002CN1378497A Water unstable foam composition
11/06/2002CN1378472A Synergy between low molecular weight heparin and platelet aggregation inhibitor, providing combination therapy for prevention and treatment of various thromboembolic disorders
11/06/2002CN1378458A Use of TGF-beta and growth factors in treatment and prevention of diseases of intestinal mucosa
11/06/2002CN1378457A Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras
11/06/2002CN1378445A Drug releasing biodegradable fiber implant
11/06/2002CN1377961A Ring structure ribo-enzyme and deoxy-ribozyme and their use
11/06/2002CN1377960A Two kinds of evolution enzyme of human ribonuclease and human lycozyme
11/06/2002CN1377891A Zinc finger protein from dendritic cell, its coding sequence and use
11/06/2002CN1377890A Method and apparatus for separating fibrin from blood plasma
11/06/2002CN1377889A Protein for causing sperm not wandering prepared from india worm lizard body cavity liquid
11/06/2002CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/06/2002CN1377711A Method for preparing degradable biologically active artificial bone
11/06/2002CN1377707A Medicinal composition for target direction transport curing cancer and its usage
11/06/2002CN1377705A Throat moistening carase tablet (sugar)
11/06/2002CN1377704A Anti-disease silk increasing agent for silk worm
11/06/2002CN1377703A Medicine for artificially inducing rockfish's sex reversion and preparing method and use
11/06/2002CN1093766C Use of thexpahyrin in preparation of medicament for use with a chemotherapeutic agent in cancer chemosensitization
11/06/2002CN1093760C Use of carbazole compounds for treating congenstive heart failure medicine
11/05/2002US6476263 Compounds for inhibiting β-amyloid peptide release and/or its synthesis
11/05/2002US6476214 Inhibition of cytokine production
11/05/2002US6476211 Methods and materials relating to CD39-like polypeptides
11/05/2002US6476207 Genes and gene expression products that are differentially regulated in prostate cancer
11/05/2002US6476206 p40 protein acts as an oncogene
11/05/2002US6476197 Polypeptides having interferon-γ inducing activity
11/05/2002US6476195 Secreted protein HNFGF20
11/05/2002US6476194 Method for folding unfolded proteins
11/05/2002US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002US6476189 Antibacterial peptides and antibacterial agents containing such peptides as an effective ingredient
11/05/2002US6476187 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
11/05/2002US6476038 Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
11/05/2002US6476005 Oral and injectable nutritional composition
11/05/2002US6476001 Facilitation of repair of neural injury with CM101/GBS toxin
11/05/2002US6475999 Method of inducing an immune response using vaccinia virus recombinants
11/05/2002US6475998 Methods and compositions for the treatment of injury to the central nervous system
11/05/2002US6475997 Methods of stimulating phagocytosis
11/05/2002US6475996 Use of a vector expressing DNA polymerase β as medicine
11/05/2002US6475989 Use of pyroglutamyl-glutamyl-prolyl amide (EEP) for neurological and neurobehavioral disorders
11/05/2002US6475988 Methods to increase white blood cell survival after chemotherapy
11/05/2002US6475987 Tall-1 receptor homologues
11/05/2002US6475986 Uses of THANK, a TNF homologue that activates apoptosis
11/05/2002US6475984 Administration of leptin
11/05/2002US6475983 Water-soluble polypeptides having a high affinity for α and β interferons
11/05/2002US6475804 Composition and method for diagnosing auto-immune hepatitis
1 ... 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 ... 3163